| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 新绿原酸; Neochlorogenic acid | CFN97472 | 906-33-2 | C16H18O9 = 354.3 | 20mg | QQ客服：1413575084 |
| 麻醉椒苫素; Methysticin | CFN90160 | 20697-20-5 | C15H14O5 = 274.27 | 10mg | QQ客服：3257982914 |
| 泽泻醇; Alismol | CFN97446 | 87827-55-2 | C15H24O = 220.4 | 10mg | QQ客服：1413575084 |
| 槐角苷; Sophoricoside | CFN90148 | 152-95-4 | C21H20O10 = 432.38 | 20mg | QQ客服：3257982914 |
| 6-羟基茜草素; 6-Hydroxyrubiadin | CFN97444 | 87686-86-0 | C15H10O5 = 270.2 | 5mg | QQ客服：2159513211 |
| 1'-O-Beta-D-吡喃葡萄糖基-3-羟基闹达柯裂亭; Smyrindioloside | CFN97442 | 87592-77-6 | C20H24O10 = 424.4 | 10mg | QQ客服：215959384 |
| 3,4,5-三甲氧基苯基6-O-D-芹糖-beta-D-呋喃糖基-beta-D-葡萄糖苷; Kelampayoside A | CFN97441 | 87562-76-3 | C20H30O13 = 478.5 | 10mg | QQ客服：215959384 |
| 箭藿苷A; Sagittatoside A | CFN90139 | 118525-35-2 | C33H40O15 = 676.67 | 5mg | QQ客服：2159513211 |
| 1,7-双苯-5-羟基-6-庚烯-3-酮; 5-Hydroxy-1,7-diphenyl-6-hepten-3-one | CFN97433 | 87095-74-7 | C19H20O2 = 280.4 | 20mg | QQ客服：1413575084 |
| 华蟾素; Cinobufotalin | CFN90137 | 1108-68-5 | C26H34O7 = 458.54 | 20mg | QQ客服：1457312923 |
| 原苏木素B; Protosappanin B | CFN90135 | 102036-29-3 | C16H16O6 = 304.30 | 20mg | QQ客服：1457312923 |
| 仙茅苷; Curculigoside | CFN97419 | 85643-19-2 | C22H26O11 = 466.4 | 20mg | QQ客服：2159513211 |
| 2-甲氧基-6-乙酰基-7-甲基胡桃酮; 2-Methoxystypandrone | CFN97412 | 85122-21-0 | C14H12O5 = 260.2 | 5mg | QQ客服：2056216494 |
| 5-表紫草氰苷; 5-Epilithospermoside | CFN97404 | 84799-31-5 | C14H19NO8 = 329.3 | 5 mg | QQ客服：2056216494 |
| 青蒿酸; Artemisinic acid | CFN97276 | 80286-58-4 | C15H22O2 = 234.3 | 20mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)